Skip to main content
Erschienen in: Hepatology International 5/2018

12.10.2018 | Editorial

Fatty liver checkmates hepatitis B virus

verfasst von: Gayatri Ramakrishna, Nirupma Trehanpati

Erschienen in: Hepatology International | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Excerpt

In Asia-Pacific region, viral infections due to hepatitis B and C viruses are major etiological risk factors for liver disease and liver failure. However, a major concern now is the emergence of non-alcoholic fatty liver disease (NAFLD). A close association between the coexistence of NAFLD with liver diseases such as hepatitis C virus, alcoholic liver disease and hemochromatosis is quite common. There are only few meta-analysis studies on the association between hepatitis B virus (HBV) and NAFLD and they are mostly these studies are from the Asia-Pacific region. Further, the fatty liver–HBV link as reported in epidemiological studies and in vitro cell culture studies are contradictory. To understand the HBV–fatty liver conundrum, a clinical animal model is of utmost importance. In this issue of Hepatology International, Hu et al. [1] have made use of the HBV-immunocompetent mouse model to demonstrate that hepatic steatosis inhibited HBV replication. …
Literatur
2.
Zurück zum Zitat Morales MR, Sendra C, Romero-Gomez M. Hepatitis B and NAFLD: lives crossed. Ann Hepatol 2017;16:185–187CrossRef Morales MR, Sendra C, Romero-Gomez M. Hepatitis B and NAFLD: lives crossed. Ann Hepatol 2017;16:185–187CrossRef
3.
Zurück zum Zitat Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow up. Hepatology 2007;45:1187–1192CrossRef Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow up. Hepatology 2007;45:1187–1192CrossRef
4.
Zurück zum Zitat Fung J, Yuen MF, Lai CL. The role of steatosis in HBsAg seroclearance for patients with chronic hepatitis B infection: fact or fiction? Dig Dis Sci 2013;58(1):20–22CrossRef Fung J, Yuen MF, Lai CL. The role of steatosis in HBsAg seroclearance for patients with chronic hepatitis B infection: fact or fiction? Dig Dis Sci 2013;58(1):20–22CrossRef
5.
Zurück zum Zitat Chu CM, Lin DY, Liaw YF. Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without. Dig Dis Sci 2013;58:275–281CrossRef Chu CM, Lin DY, Liaw YF. Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without. Dig Dis Sci 2013;58:275–281CrossRef
6.
Zurück zum Zitat Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology 2010;139(2):474–482CrossRef Liu J, Yang HI, Lee MH, Lu SN, Jen CL, Wang LY, et al. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology 2010;139(2):474–482CrossRef
7.
Zurück zum Zitat Zhang Z, Pan Q, Duan XY, Liu Q, Mo GY, Rao GR, et al. Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model. J Gastroenterol Hepatol 2012;27(12):1858–1864CrossRef Zhang Z, Pan Q, Duan XY, Liu Q, Mo GY, Rao GR, et al. Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model. J Gastroenterol Hepatol 2012;27(12):1858–1864CrossRef
8.
Zurück zum Zitat Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, et al. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci USA 2015;112(7):2175–2180CrossRef Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, et al. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci USA 2015;112(7):2175–2180CrossRef
9.
Zurück zum Zitat Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 2007;132:1955–1967CrossRef Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 2007;132:1955–1967CrossRef
10.
Zurück zum Zitat Joo EJ, Chang Y, Yeom JS, Ryu S. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: a cohort study. Hepatology 2017;65:828–835CrossRef Joo EJ, Chang Y, Yeom JS, Ryu S. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: a cohort study. Hepatology 2017;65:828–835CrossRef
11.
Zurück zum Zitat Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol 2011;26(9):1361–1367PubMed Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol 2011;26(9):1361–1367PubMed
12.
Zurück zum Zitat Rastogi A, Sakhuja P, Kumar A, Hissar S, Jain A, Gondal R, et al. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Microbiol 2011;54:454–459CrossRef Rastogi A, Sakhuja P, Kumar A, Hissar S, Jain A, Gondal R, et al. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Microbiol 2011;54:454–459CrossRef
Metadaten
Titel
Fatty liver checkmates hepatitis B virus
verfasst von
Gayatri Ramakrishna
Nirupma Trehanpati
Publikationsdatum
12.10.2018
Verlag
Springer India
Erschienen in
Hepatology International / Ausgabe 5/2018
Print ISSN: 1936-0533
Elektronische ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-018-9903-9

Weitere Artikel der Ausgabe 5/2018

Hepatology International 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.